Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Drugs & Aging
|
May 1, 1997
Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension
J A Balfour, M I Wilde
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Interferon-alpha-2a: a review of its use in chronic hepatitis C
C M Perry, M I Wilde
Drugs
|
September 1, 1997
Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders
H D Langtry, M I Wilde
Drugs
|
October 20, 1998
Milnacipran. A review of its use in depression
C M Spencer, M I Wilde
Drugs
|
August 1, 1995
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations
M I Wilde, J A Balfour
Drugs & Aging
|
June 1, 1996
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
H M Bryson, M I Wilde
Drugs
|
June 1, 1997
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification
M I Wilde, A J Wagstaff
Drugs
|
November 26, 1998
Dienogest
R H Foster, M I Wilde
Drugs
|
March 1, 1993
Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia
M I Wilde, A Fitton, D McTavish
Drugs
|
November 1, 1993
Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness
M I Wilde, G L Plosker, P Benfield
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Drugs & Aging
|
May 1, 1997
Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension
J A Balfour, M I Wilde
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Interferon-alpha-2a: a review of its use in chronic hepatitis C
C M Perry, M I Wilde
Drugs
|
September 1, 1997
Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders
H D Langtry, M I Wilde
Drugs
|
October 20, 1998
Milnacipran. A review of its use in depression
C M Spencer, M I Wilde
Drugs
|
August 1, 1995
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations
M I Wilde, J A Balfour
Drugs & Aging
|
June 1, 1996
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
H M Bryson, M I Wilde
Drugs
|
June 1, 1997
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification
M I Wilde, A J Wagstaff
Drugs
|
November 26, 1998
Dienogest
R H Foster, M I Wilde
Drugs
|
March 1, 1993
Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia
M I Wilde, A Fitton, D McTavish
Drugs
|
November 1, 1993
Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness
M I Wilde, G L Plosker, P Benfield
Page
of 4